PRVA (Privia Health Group Inc) climbed 0.51 at the last close: Is This Today’s Most Popular Stock?

Privia Health Group Inc (NASDAQ: PRVA) on Tuesday, soared 0.51% from the previous trading day, before settling in for the closing price of $21.51. Within the past 52 weeks, PRVA’s price has moved between $15.92 and $24.30.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 20.87% over the last five years. The company achieved an average annual earnings per share of -30.86%. With a float of $106.24 million, this company’s outstanding shares have now reached $119.95 million.

The firm has a total of 1102 workers. Let’s measure their productivity. In terms of profitability, gross margin is 9.47%, operating margin of 0.77%, and the pretax margin is 1.41%.

Privia Health Group Inc (PRVA) Breakdown of a Key Holders of the stock

Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Privia Health Group Inc is 11.47%, while institutional ownership is 97.20%. The most recent insider transaction that took place on Sep 10 ’24, was worth 2,500,127. In this transaction Chief Executive Officer of this company sold 135,142 shares at a rate of $18.50, taking the stock ownership to the 247,771 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 135,142 for $18.50, making the entire transaction worth $2,500,719.

Privia Health Group Inc (PRVA) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -30.86% per share during the next fiscal year.

Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators

Privia Health Group Inc (PRVA) is currently performing well based on its current performance indicators. A quick ratio of 1.78 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.51. Likewise, its price to free cash flow for the trailing twelve months is 27.73.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.10, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.26 in one year’s time.

Technical Analysis of Privia Health Group Inc (PRVA)

Analysing the last 5-days average volume posted by the [Privia Health Group Inc, PRVA], we can find that recorded value of 0.45 million was lower than the volume posted last year of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 24.97%. Additionally, its Average True Range was 0.80.

During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 76.69%, which indicates a significant increase from 51.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.44% in the past 14 days, which was lower than the 41.84% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $19.66, while its 200-day Moving Average is $19.01. Now, the first resistance to watch is $21.91. This is followed by the second major resistance level at $22.19. The third major resistance level sits at $22.64. If the price goes on to break the first support level at $21.18, it is likely to go to the next support level at $20.73. Now, if the price goes above the second support level, the third support stands at $20.45.

Privia Health Group Inc (NASDAQ: PRVA) Key Stats

Market capitalization of the company is 2.59 billion based on 120,001K outstanding shares. Right now, sales total 1,658 M and income totals 23,080 K. The company made 437,920 K in profit during its latest quarter, and 3,540 K in sales during its previous quarter.